cytena's single-cell printer is a unique device for separating, sorting and handling of single biological cells. For the first time this method enables an automated, separation of single cells with high viability and proof of clonality without cross-contamination risks.
Jonas Schoendube (M.Sc. | CEO)
Andre Gross (Dipl.-Ing. | CTO)
Benjamin Steimle (Dipl.-Vw. | CFO)
Dr. Peter Koltay (Dipl. Phys. | Business Development)
EUR 3 million in series A for the growth and development of Cytena GmbH
cytena, a University of Freiburg spin-off, received EUR 1.1 million of seed capital from HTGF and a private investor
Info & Contact